IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer

被引:20
|
作者
Westeel, V.
Lebitasy, M. P.
Mercier, M.
Girard, P.
Barlesi, F.
Blanchon, F.
Tredaniel, J.
Bonnette, P.
Woronoff-Lemsi, M. C.
Breton, J. L.
Azarian, R.
Falcoz, P. E.
Friard, S.
Geriniere, L.
Laporte, S.
Lemarie, E.
Quoix, E.
Zalcman, G.
Guigay, J.
Morin, F.
Milleron, B.
Depierre, A.
机构
[1] Univ Franche Comte, CHU Besancon, Serv Pneumol, F-25030 Besancon, France
[2] IFCT, Paris, France
[3] Univ Franche Comte, Serv Biomath, F-25030 Besancon, France
[4] Ctr Mutualiste Montsouris, Paris, France
[5] APHM, Marseille, France
[6] APHP Hop St Louis, Paris, France
[7] Ctr Hosp Foch, Suresnes, France
[8] CH Versailles, Versailles, France
[9] Hop Foch, Suresnes, France
[10] Ctr Hosp Lyon Sud, HCL, F-69310 Pierre Benite, France
[11] CHU Tours, Tours, France
[12] CHU Strasbourg, F-67000 Strasbourg, France
[13] CHU Caen, F-14000 Caen, France
[14] Inst Gustave Roussy, Villejuif, France
[15] APHP Hop Tenon, Paris, France
关键词
lung cancer; post-operative follow-up; randomised trial; surgery; non-small cell lung cancer;
D O I
10.1016/S0761-8425(07)91135-3
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background The authorities advocate a minimalist attitude towards the follow-up of resected bronchial carcinoma (clinical examination and chest x-ray). A survey showed that 70% of French respiratory physicians have chosen to use the CT scanner and often endoscopy. The published data are equivocal and are often based on retrospective studies. Lung cancer is a good model for a study of post-operative surveillance. Recurrences often occur in easily observed areas, they may be detected while still asymptomatic and are sometimes potentially curable. Second primary tumours may develop at the same site. Methods The Intergroupe Francophone de Cancerologie Thoracique (IFCT) has initiated a trial comparing simple follow-up (clinical examination, chest x-ray) with a more intensive followup (CT scan, fibreoptic bronchoscopy). The surveillance will take place every 6 months for 2 years and then annually until 5 years. Expected results The main aim is to determine whether intensive follow-up improves patient survival. The opposite question is equally important. If an expensive and demanding follow-up does not affect the chances of cure these results will influence our practice.
引用
收藏
页码:645 / 652
页数:8
相关论文
共 50 条
  • [1] Compliance with Follow-Up Programs After Surgery for Non-Small Cell Lung Cancer in the Phase III IFCT-0302 Trial
    Westeel, Virginie
    Barlesi, Fabrice
    Foucher, Pascal
    Lafitte, Jean-Jacques
    Domas, Jean
    Girard, Philippe
    Tredaniel, Jean
    Wislez, Marie
    Dumont, Patrick
    Quoix, Elisabeth
    Raffy, Olivier
    Braun, Denis
    Derollez, Marc
    Goupil, Francois
    Hermann, Jacques
    Devin, Etienne
    Lebitasy, Marie Paule
    Morin, Franck
    Zalcman, Gerard
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S239 - S239
  • [2] Recurrence Dynamic of Completely Resected Non-Small Cell Lung Cancer in Perspective of Follow-Up Surveillance
    Kim, Eung Rae
    Park, In Kyu
    Hyun, Kwanyong
    Park, Samina
    Hwang, Yoohwa
    Kang, Chang Hyun
    Kim, Young Tae
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1395 - S1395
  • [3] Postoperative follow-up in non-small cell lung cancer
    Westeel, V
    REVUE DES MALADIES RESPIRATOIRES, 2005, 22 (06) : S90 - S93
  • [4] Postoperative Follow-Up for Patients with Non-Small Cell Lung Cancer
    Nakamura, Ryota
    Kurishima, Koichi
    Kobayashi, Naohiro
    Ishikawa, Shigemi
    Goto, Yukinobu
    Sakai, Mitsuaki
    Onizuka, Masataka
    Ishikawa, Hiroichi
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    Sato, Yukio
    ONKOLOGIE, 2010, 33 (1-2): : 14 - 18
  • [5] A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT 0002 trial)
    Westeel, Virginie
    Quoix, Elisabeth
    Puyraveau, Marc
    Lavole, A.
    Braun, Denis
    Laporte, Silvy
    Bigay-Game, Laurence
    Pujol, Jean-Louis
    Ozenne, Gervais
    Riviere, Alain
    Douillard, Jean-Yves
    Lebeau, Bernard
    Debieuvre, Didier
    Poudenx, Michel
    David, Philippe
    Molinier, Olivier
    Zalcman, Gerard
    Lemarie, Etienne
    Morin, Franck
    Depierre, Alain
    Milleron, Bernard
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (12) : 2654 - 2664
  • [6] The role of Radiological follow-up protocol in patients with surgically resected Non-Small Cell Lung Cancer
    Salman, Rashad
    Robson, Jonathan
    Quinn, Thomas
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [7] Evidence-based follow-up in non-small cell lung cancer
    Watzka, Stefan B.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (01) : 69 - 72
  • [8] Evidence-based follow-up in non-small cell lung cancer
    Stefan B. Watzka
    memo - Magazine of European Medical Oncology, 2020, 13 : 69 - 72
  • [9] Significance of the serum carcinoembryonic antigen level during the follow-up of patients with completely resected non-small-cell lung cancer
    Ozeki, Naoki
    Fukui, Takayuki
    Taniguchi, Tetsuo
    Usami, Noriyasu
    Kawaguchi, Koji
    Ito, Simon
    Sakao, Yukinori
    Mitsudomi, Tetsuya
    Hirakawa, Akihiro
    Yokoi, Kohei
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2014, 45 (04) : 687 - 692
  • [10] Randomised study of adjuvant chemotherapy for completely resected p-stage I–IIIA non-small cell lung cancer
    K Nakagawa
    H Tada
    A Akashi
    T Yasumitsu
    K Iuchi
    T Taki
    K Kodama
    British Journal of Cancer, 2006, 95 : 817 - 821